Office of Technology Management

Total Page:16

File Type:pdf, Size:1020Kb

Office of Technology Management chnology ent O Te M m ffi of a e c na g e e g a o c n fi e a f f m T M e O e c y n h g t n o l o o l o n g h y c O t M e n f T fi e a f c n e o m a e o e g g c f e a fi T m f n e a e O c n h M t n y o g l o U I C Office of Technology Management Fiscal Year 2007 Annual Report • University of Illinois at Chicago Office of Technology Management • University of Illinois at Chicago (MC 682) 1853 West Polk Street, Suite 446 • Chicago, Illinois 60612 312.996.7018 • [email protected] • www.otm.uic.edu Copyright © 2007 The Board of Trustees at the University of Illinois All Rights Reserved Contents From the Director 03 About the Office 04 Invention Disclosures 05 Licensing Activity 05 Patent Activity 06 Income Distribution 08 Income and Expenses 08 FDA-Approved Drug 09 Technologies 10 Contacts 14 Reporting Looking Ahead: Fiscal 2008 Goals The Office of Technology Management (OTM) reports to Dr. A report on fiscal 2007 activity would be incomplete without Avijit Ghosh, the Vice President for Technology and Economic looking ahead to fiscal 2008. Our focus in the coming year Development, and also works closely with the Interim Vice will be on the following areas, each designed to build on or Chancellor for Research, Larry H. Danziger. consolidate the gains we’ve made over the last few years: Mission • Host intellectual property seminars and events for OTM works to ensure that UIC maintains its reputation as faculty and graduate students. a world class research institution with an outstanding faculty. • Attend tradeshows and conferences, We rely on our staff, external contacts, and legal, business, acquiring qualified contacts at each. and financial expertise to support inventors and help partner • Implement feedback mechanisms for faculty and companies develop UIC technologies. licensees; address survey feedback as appropriate. • Update information systems and other processes, Two of our most critical missions are supporting and including an update of the office website and installing encouraging UIC inventors and helping commercial firms a new content management system. license UIC technologies. Fiscal 2007 Snapshot Disclosures 117 U.S. Patents Filed 162 U.S. Patents Issued 10 Licenses and Options 12 Licenses to Start-up companies 1 Royalties $4,052,586 Patent Expense Reimbursement $291,324 2 2007 Fiscal Year Annual Report From The Interim Director, David Gulley In 2007, the UIC OTM had a very productive and successful year. Our first FDA approved drug went to market—PrezistaTM, a new protease inhibitor for drug- resistant strains of HIV. This was the result of research collaborations in the 1990s among several groups, including UIC’s Arun Ghosh (now at Purdue University). You can read more on page 9. Our 2007 customer satisfaction survey reported the satisfaction level of our licensees and inventors. Eighty-seven percent (87%) of our licensees responding to the survey reported their interactions with the OTM were either satisfactory or very satisfactory, while about 88% of UIC inventors felt the OTM had met or exceeded their expectations. Other accomplishments for 2007 included improvements to our licensing and other agreements; the introduction of a new start-up license template; educational seminars for faculty and others; focused business partnering at industry events; preparing for the OTM’s move into new space; and a successful collaboration with the College of Business to enable teams of MBA students to develop business plans that won regional and national competitions. For 2008 our plans include completing the relocation of the OTM; increasing our level of engagement and targeting of potential licensees; continuing our patent enforcement and license compliance efforts; expanding our educational programs for faculty and staff; enhancing our relationship with the College of Business Administration; and increasing our collaboration with UIUC’s OTM to support scaled- up web-based marketing and communications. Since April 2007, it has been my pleasure to work with such a dedicated and enthusiastic team of professionals at the OTM. I thank them for their commitment to making a difference and posi- tively impacting people’s lives. We look forward to a successful 2008 and I welcome your feedback on how we can improve our service to you and the campus. David L. Gulley, Ph.D. Interim Director and Associate Vice President for Technology and Economic Development 3 2007 Fiscal Year Annual Report About the Office of Technology Management The Office of Technology Management (OTM) currently has 14 full-time equivalent employees, 6 part-time student interns, and numerous outside business and legal consultants at its disposal. The office has adopted a documented, systematic and timely process for the analysis, protection, and commercialization of university intellectual property. In addition, the OTM has developed ongoing productive relationships with faculty, staff and industry. Due to the foresight, efforts and support from campus, University leadership, and the University’s Board of Trustees, the OTM is surrounded by a more vibrant entrepreneurial environment than ever before. This environment facilitates technology transfer activities, the formation of start-up companies, and ultimately local and state economic development. The OTM Process U.S. Patenting / U.S., Foreign Patenting Licensing Research Summaries Screening Assessment Marketing License Compliance Disclosed Evaluation Negotiations DISCLOSURES OF RESEARCH SUMMARIES The OTM actively reaches out to faculty to encourage invention disclosures, called “research summaries” of potentially commer- cializable intellectual property. LICENSING ● Screening Evaluation ● Marketing Within six to eight weeks of receiving a disclosure, a screening Considerable time and resources are devoted to researching team presents a business-case analysis, called a screening and contacting the best possible licensing partners. evaluation, to the office with a recommended course of action ● License Negotiations regarding commercialization. The results of the screening The OTM conducts license negotiations with interested industry evaluation are then presented to the inventors. partners, taking care to formulate the best possible agreements. ● Assessment ● Compliance When warranted, a more thorough business analysis is After a technology is licensed, the OTM continues to monitor completed which may involve the services of outside consultants the licensee to ensure all terms and conditions are adhered to, to connect with industry experts. This adds to the OTM’s and the technology is successfully taken to market. understanding of the potential market for the technology and 4 helps determine further patenting and marketing actions. 2007 Fiscal Year Annual Report Invention Disclosures The Office of Technology Management provides a variety of Fiscal 2007 Disclosures by College/Unit educational and informative events for the campus community. Applied Health Sciences 2 Liberal Arts and Sciences 14 In fiscal 2007 we focused on department specific events and Dentistry 1 Medicine 61 one-on-one meetings with faculty across campus. We also Education 1 Nursing 1 hosted an inventor recognition gathering co-sponsored by Engineering 20 Pharmacy 14 the Colleges of Business, Pharmacy, and Medicine. Fiscal 2007 Disclosures by Type Campus Invention Disclosures: The types of disclosure are determined by OTM and used on Fiscal 2003-Fiscal 2007 our website and flyers to facilitate industry identification of During the fiscal year, ending June 30, 2007, 117 inventions technologies of interest. were disclosed by the Chicago campus. • Anitbodies 1 • Health Information 3 • Cardiovascular 6 • Immunology 3 150 • CNS 5 • Infectious Disease 4 • Communications 2 • Inflammation 3 120 122 • Data Organization 12 • Materials 3 117 • Dental 2 • Miscellaneous 24 90 • Diagnostic 4 • Oncology 8 87 83 84 • Drug Delivery 10 • Opthamology 2 60 • Engineering 12 • Proteomics 1 s • Graphics, Visualization 2 • Research Tools 2 30 • Hardware 1 • Stem Cells 4 • Health Imaging 4 FY03 FY04 FY05 FY06 FY07 Disclosure Licensing Activity Licenses and Options: Fiscal 2003-Fiscal 2007 Number of Start-Ups: Fiscal 2003-Fiscal 2007 35 33 30 8 28 25 7 6 5 5 5 15 4 14 12 3 2 5 1 1 1 1 FY03 FY04 FY05 FY06 FY07 FY03FY03 FY04FY04 FY05FY05 FY06FY06 FYFY07 Fiscal 2007 Licenses and Start-up Companies Licensed in Fiscal 2007 Options by College/Unit OrthoAccel Technologies, Inc. Dentistry 4 OrthoAccell Technologies designs, develops, markets, Engineering 1 and sells a revolutionary orthodontic device which reduces Liberal Arts and Sciences 2 the treatment time for braces by half. Medicine 4 Public Health 1 5 2007 Fiscal Year Annual Report Patent Activity A patent is a property right granted by the U.S. Government Provisional applications can be filed without claims, inventor- or other foreign government that allows inventors (and patent ship determinations or formal papers. They merely “hold the owners) to receive value for their intellectual innovations by date of filing” however, and will not result in a patent issued by providing the patent holder with a time-limited (20 years in the the U.S. Patent and Trademark Office. They must be followed U.S.) exclusive monopoly. In exchange, the patent describing up with a regular (non-provisional) U.S. patent filing within a the new innovation is published, thereby advancing general year’s time in order to obtain patent protection. knowledge and contributing to growth in that field. Patent property rights are like other property, and can be In the U.S., patent applications can be of two general types: sold, leased or transferred to others for “royalties,” most often provisional or non-provisional (“regular” applications). Provisional through licensing. applications are often used to file quickly when necessary to preserve the right to file US or foreign applications at a later time. Fiscal 2007 Patent Activity Fiscal 2007 U.S. Patent by College/Unit Filed Issued U.S.
Recommended publications
  • FISCAL from the Directors
    FISCAL From The Directors Dear Colleagues, Advisory Boards for Fiscal 2011 This year marks a decade of strong commitment to technology transfer and economic development at the University of Illinois. It is fitting that this is also the year the Board of Trustees created Urbana the Office of the Vice President for Research and appointed Larry Schook as Interim Vice President, enabling the next step in the evolution of our offices. Bruce Vojak, Chair Van Anderson Advocacy and value creation have been the hallmarks of our Hans Blaschek accomplishments this past year as demonstrated in each Scott Carney initiative and achievement. Proof of concept funding programs Albert Feng on both campuses will help attract licensing partners for our Merle Giles high potential technologies. And joining with other top research Gregory Girolami universities to work with Osage University Partners will help us Gaines Hall realize the financial potential inherent in the preemptive rights Wen-Mei Hwu that are included in most licenses to University start-ups. Jozef Kokini Philip Krein The University of Illinois at Chicago, together with the NIH, Steven Leigh became the first in the world to share patents with Unitaid’s Paul Magelli Medicines Patent Pool, which makes new medicines more Romana Nowak affordable in developing countries. The Urbana campus Michael Philpott developed a unique label license for MIDA boronate technology Jennifer Quirk that enables Sigma-Aldrich and other suppliers to offer its Molly Tracy customers a royalty free license to the University’s intellectual David Weightman property, thus encouraging broad adoption of the technology in Huimin Zhao multiple industries.
    [Show full text]
  • Brain Research Institute. Director. Administrative Files. 1949-1984
    http://oac.cdlib.org/findaid/ark:/13030/c8wm1fsv No online items Brain Research Institute. Director. Administrative files. 1949-1984. Finding aid prepared by University Archives staff, 1990 May; finding aid revised by Katharine A. Lawrie, 2013 June; machine-readable finding aid created by Katharine A. Lawrie, 2013 June. UCLA Library Special Collections Room A1713, Charles E. Young Research Library Box 951575 Los Angeles, CA, 90095-1575 (310) 825-4988 [email protected] ©1990 May Brain Research Institute. University Archives Record Series 371 1 Director. Administrative files. 1949-1984. Title: Brain Research Institute. Director. Administrative files. Identifier/Call Number: University Archives Record Series 371 Contributing Institution: UCLA Library Special Collections Language of Material: English Physical Description: 22.8 linear ft.(57 boxes) Date (bulk): Bulk, 1957-1984 Date (inclusive): 1949-1984 Abstract: Record Series 371 contains the administrative files of the directory of UCLA's Brain Research Institute. Creator: Brain Research Institute. Access COLLECTION STORED OFF-SITE AT SRLF: Open for research. Advance notice required for access. Contact the UCLA Library Special Collections Reference Desk for paging information. Publication Rights Copyright of portions of this collection has been assigned to The Regents of the University of California. The UCLA University Archives can grant permission to publish for materials to which it holds the copyright. All requests for permission to publish or quote must be submitted in writing to the UCLA University Archivist. Preferred Citation [Identification of item], Brain Research Institute. Director. Administrative files (University Archives Record Series 371). UCLA Library Special Collections, University Archives. Scope and Content Record Series 371 contains the administrative files of the directory of UCLA's Brain Research Institute.
    [Show full text]
  • Future Flames, Families Check out UIC Campus 5 More on Page 9 UIC MAKES FINAL PRESIDENTIAL LIBRARY LIST 7 MULTIMEDIA MAKEOVER for LECTURE CENTER A
    SEPTEMBER 17, 2014 I UIC NEWS I uicnews.uic.edu September 17 2014 VOLUME 34 / NUMBER 4 For the community of the University of Illinois at Chicago uicnews.uic.edu 2 ANDREW MODDRELL REINVENTS THE L.A. RIVERBED OPEN 3 ‘PORTRAITS OF A SOLDIER’ HONORS HOUSE FALLEN MILITARY Future Flames, families check out UIC campus 5 more on page 9 UIC MAKES FINAL PRESIDENTIAL LIBRARY LIST 7 MULTIMEDIA MAKEOVER FOR LECTURE CENTER A INSIDE: CAMPUS NEWS 4 CALENDAR 8 POLICE / DEATHS 10 SPORTS 12 facebook.com/uicnews twitter.com/uicnews youtube.com/uicmedia — Photo: Julie Jaidinger 2 uicnews.uic.edu I UIC NEWS I SEPTEMBER 17, 2014 send profile ideas to Gary Wisby, [email protected] PROFILE ANDREW MODDRELL Reimagining play, reinventing riverbed By Gary Wisby — [email protected] After more than a year’s work on a new $5 million design for Denver’s City Park, Andrew Moddrell is back to the drawing board. Nine months in, the project ran into opposition from a neighborhood group of about 100 people. “They don’t want their park to change,” said Moddrell, assistant professor of ar- chitecture and partner in PORT Archi- tecture and Urbanism. PORT partnered on the project with Denver-based Indie Architecture, run by UIC School of Architecture faculty mem- Andrew Moddrell is collaborating on the design of a Denver park and 51 miles of greenway along the Los Angeles River, now ber Paul Andersen. a concrete channel. “A lot of people in L.A. don’t know they have a river,” says Moddrell, assistant professor of architecture.
    [Show full text]
  • NASA National Aeronautics and Space Administration
    ACCESSION NUMBER RANGES Accession numbers cited in this Supplement faii within rne following ranges. STAR (N-10000 Series) N87-21846 - N87-23569 IAA (A-10000 Series) A87-35191 - A87-39224 NASA SP-7011(301) AND BIOLOGY A CONTINUING BIBLIOGRAPHY WITH INDEXES (Supplement 301) A selection of annotated references to unclassified reports and journal articles that were introduced into the NASA scientific and technical information system and announced in August 1987 in 9 Scientific and Technical Aerospace Reports (STAR) International Aerospace Abstracts (IAA). Scientific and Technical Information Division 1987 NASA National Aeronautics and Space Administration Washington, DC This supplement is available from the National Technical Information Service (NTIS), Springfield, Virginia 22161, price code A05. INTRODUCTION This Supplement to Aerospace Medicine andBioIogylists 217 reports, articles and other documents announced during August 1987 in Scientific and TechnicalAerospace Reports (STAR)or in International Aerospace Abstracts (IAA). The first issue of the bibliography was published in July 1964. In its subject coverage, Aerospace Medicine andBioIogyconcentrates on the biological, physiolog- ical, psychological, and environmental effects to which man is subjected during and following simulated or actual flight in the Earth’s atmosphere or in interplanetary space. References describing similar effects of biological organisms of lower order are also included. Such related topics as sanitary problems, pharmacology, toxicology, safety and survival, life support systems, exobiology, and person- nel factors receive appropriate attention. In general, emphasis is placed on applied research, but references to fundamental studies and theoretical principles related to experimental development also qualify for inclusion. Each entry in the bibliography consists of a bibliographic citation accompanied in most cases by an abstract.
    [Show full text]
  • Medicinski Pregled Časopis Društva Lekara Vojvodine Srpskog Lekarskog Društva Prvi Broj Je Štampan 1948
    Izdavačka delatnost Društva lekara Vojvodine Srpskog lekarskog društva, Novi Sad, Vase Stajića 9 Glavni i odgovorni urednik: prof. dr GORDANA DEVEČERSKI MEDICINSKI PREGLED ČASOPIS DRUŠTVA LEKARA VOJVODINE SRPSKOG LEKARSKOG DRUŠTVA PRVI BROJ JE ŠTAMPAN 1948. GODINE. Glavni i odgovorni urednik Prof. dr LJILJA MIJATOV UKROPINA Pomoćnici urednika Doc. dr BILJANA SRDIĆ GALIĆ Doc. dr VLADIMIR PETROVIĆ REDAKCIJSKI ODBOR Predsednik: prof. dr PETAR SLANKAMENAC Sekretar: prof. dr VIKTOR TILL Prof. dr STOJANKA ALEKSIĆ, Hamburg Prof. dr SMILJANA MARINKOVIĆ, Novi Sad Prof. dr KAREN BELKIĆ, Stockholm Prof. dr MARIOS MARSELOS, loannina Prof. dr JEAN-PAUL BEREGI, Lille Cedex Prof. dr LJILJA MIJATOV UKROPINA, Novi Sad Prof. dr JELA BOROTA, Novi Sad Prof. dr MIROSLAV MILANKOV, Novi Sad Prof. dr MILAN BREBERINA. Novi Sad Prof. dr IGOR MITIĆ, Novi Sad Prof. dr RADOVAN CVIJANOVIĆ, Novi Sad Prof. dr NADA NAUMOVIĆ. Novi Sad Prof. dr GROZDANA ČANAK, Novi Sad Prof. dr ANA OROS, Novi Sad Prof. dr IVAN DAMJANOV, Kansas City Prof. dr VERA JERANT PATIĆ, Novi Sad Prof. dr DRAGAN DANKUC, Novi Sad Prof. dr LJUBOMIR PETROVIĆ, Novi Sad Prof. dr GORDANA DEVEČERSKI, Novi Sad Prof. dr MIODRAG RADULOVAČKI, Chicago Prof. dr RAJKO DOLEČEK, Ostrava Prof. dr JOVAN RAJS, Danderyd Prof. dr MIRJANA ĐERIĆ, Novi Sad Prof. dr ALEKSANDAR ROZENBERGER, Haifa Prof. dr SRĐAN ĐURĐEVIĆ, Novi Sad Prof. dr PETAR E. SCHWARTZ, New Haven Prof. dr VERA GRUJIĆ, Novi Sad Prof. dr PETAR SLANKAMENAC, Novi Sad Prof. dr TATJANA IVKOVIĆ LAZAR, Novi Sad Prof. dr VIKTOR TILL, Novi Sad Prof. dr JÁNOS JAKÓ, Budapest Prof. dr TAKASHI TOYONAGA. Kobe Prof. dr MARINA JOVANOVIĆ, Novi Sad Prof.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,303,595 B1 Andrews (45) Date of Patent: Oct
    USOO6303595B1 (12) United States Patent (10) Patent No.: US 6,303,595 B1 Andrews (45) Date of Patent: Oct. 16, 2001 (54) USE OF MIRTAZAPINE FOR TREATING WO 97 22339 6/1997 (WO). SLEEP APNEAS OTHER PUBLICATIONS (75) Inventor: John Stuart Andrews, Schilde (BE) Stimmel et al., Pharmacotherapy, Vo. 17, #1, pp. 10-21 (abstract), Jan. 1997.* (73) Assignee: Akzo Nobel N.V., Arnhem (NL) Hanzel et al., Chest, vol. 100, #2, pp. 416–421 (abstract), (*) Notice: Subject to any disclaimer, the term of this Aug. 1991.* patent is extended or adjusted under 35 Terra, Ann. Pharmacother., vol. 31, #6, pp. 776-768 (abstract), Jun. 1997.* U.S.C. 154(b) by 0 days. Carley et al, Am. J. Respir. Crit. Care Med., vol. 160, pp. (21) Appl. No.: 09/554,143 1624-1629, 1999.* Radulovacki et al., “Serotonin 5-HT-receptor Antagonist (22) PCT Filed: Nov. 13, 1998 GR 38032F Suppresses Sleep Apneas in Rats,” Sleep, vol. (86) PCT No.: PCT/EP98/07330 21, No. 2, 1998, pp. 131-136. M.Yoshioka et al., “Pharmacological Characterization of S371 Date: Jul. 14, 2000 5-Hydroxytryptamine-Induced Apnea in the Rat,” Journal S 102(e) Date: Jul. 14, 2000 of Pharmacology and Experimental Therapeutics, vol. 260, No. 2, 1992, pp. 917-924. (87) PCT Pub. No.: WO99/25356 Th. de Boer, Ph.D, “The Pharmacologic Profile of Mirtaza pine,” J Clin Psychiatry, 1996:57 (Suppl 4), pp. 19-25. PCT Pub. Date: May 27, 1999 G.L. Stimmel et al., “Mirtazapine: An Antidepressant with (30) Foreign Application Priority Data Noradrenergic and Specific Serotonergic Effects.” Pharma cotherapy, vol.
    [Show full text]
  • The Physiologist
    The A Publication of The American Physiological Society Physiologist Volume 41 Number 3 June 1998 Check out www.ajpcon.org Citation Statistics for the Individual Journals of AJP Online The American Journal of Physiology Brenda B. Rauner Inside Journal Impact: The Institute for Scientific Information (ISI) the years ISI has only provided the Impact Does it Matter? publishes Impact Factors for 60 journals in its Factors for the consolidated AJP. In 1994 the Physiology category. Table 1 provides a ranking Publications Committee commissioned ISI to p.113 of the top 16 physiology journals in 1996. This provide us with this information because of our Impact Factor is based on the citations to a jour- need to know the citation history of the individ- nal of items published in 1995 and 1996,divided ual journals. The results were published in the Guyton by the total number of items published by a June 1995 issue of The Physiologist. The Teacher of the journal in those two years. The top-ranking Society asked ISI to update the study in 1998, Year Award physiology journal was the Society’s and the results are published here for your infor- Physiological Reviews(PRV),with an Impact mation. Even though Impact Factors per se were p.116 Factor of 19.38. The American Journal of not obtained because of the study design,the Physiologywas ranked 8th among 60 physiology analysis did provide the Society with useful cita- journals with an Impact Factor of 3.32. For other tion statistics. As in 1994,the study determined Request for Society journals,the Journal of Neurophysiology the number of times an individual AJPjournal Bowditch/ (JN) ranked 7th,News in Physiological Sciences bibliographic published item was cited in the ISI Cannon (NIPS) ranked 15th,and the Journal of Applied database of approximately 4,500 biomedical Physiology (JAP) ranked 16th.
    [Show full text]
  • Sremski Karlovci Sremski in Collection Cellar Wine
    NOVO HOPOVO MONASTERY HOPOVO NOVO COBISS.SR-ID 332121607 COBISS.SR-ID ISBN 978-86-81528-46-4 ISBN 711.4(497.113 Sremski Karlovci)(084.3) Sremski 711.4(497.113 338.48(Sremski Karlovci)(036) Karlovci)(036) 338.48(Sremski Библиотека Матице српске, Нови Сад Нови српске, Матице Библиотека CIP - Каталогизација у публикацији у Каталогизација - CIP far from Novi Sad. Novi from far Sremski Karlovci is 60 km far from Belgrade, and 11 km km 11 and Belgrade, from far km 60 is Karlovci Sremski Novi Sad, 2019 Sad, Novi of great significance for the Serbian culture. culture. Serbian the for significance great of ISBN 978-86-81528-46-4 ISBN century. Some of them, like Hopovo and Krušedol, are are Krušedol, and Hopovo like them, of Some century. Print run of 8,000 copies 8,000 of run Print 16 the from mainly dating monasteries sixteen are th Printed by: Printshop “Futura” Printshop by: Printed of Sremski Karlovci, on the hills of Fruška Gora, there there Gora, Fruška of hills the on Karlovci, Sremski of THE MONASTERIES OF FRUŠKA GORA – in the vicinity vicinity the in – GORA FRUŠKA OF MONASTERIES THE Nenad Nedomački, TONS archive TONS Nedomački, Nenad Photographs: Aleksandar Milutinović, Dragan Kurucić, Dragan Milutinović, Aleksandar Photographs: was buried there. buried was Graphic Solutions Graphic pre-press: and Design Radičević, a pupil of the Karlovci Grammar School, School, Grammar Karlovci the of pupil a Radičević, Map design: Grafički studio Žiža – Graphic studio Žiža studio Graphic – Žiža studio Grafički design: Map and the fact that the famous Serbian poet Branko Branko poet Serbian famous the that fact the and Sremski Karlovci.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,053,413 B2 Carley Et Al
    USOO8053413B2 (12) United States Patent (10) Patent No.: US 8,053,413 B2 Carley et al. (45) Date of Patent: Nov. 8, 2011 (54) METHODS FORTREATING SLEEP 5,688,943 A 1 1/1997 Ryder et al. .................. 540,509 DISORDERS BY CHOLECYSTOKININ (CCK) 3. A 38. Sealyder et al. ....... SS RECEPTOR BANTAGONSTS 6,075,033. A 6/2000 Makovec et al. .............. 514,278 2004/O198723 A1 10, 2004 Gibson (75) Inventors: David W. Carley, Evanston, IL (US); Miodrag Radulovacki, Chicago, IL OTHER PUBLICATIONS (US) Burgess et al. J of Cell Bio. 1990, 111:2129-2138.* (73) Assignee: The Board of Trustees of the Bowie et al. Science, 1990, 247: 1306-1310.* University of Illinois, Chicago, IL (US) Pawson et al. 2003, Science 300:445-452.* Widdop et al., “Electrophysiological and autoradiographical evi (*) Notice: Subject to any disclaimer, the term of this dence for cholecystokinin A receptors on rat isolated nodose patent is extended or adjusted under 35 gangila'. J. Autonomic Nervous System 1993 46:65-73. U.S.C. 154(b) by 571 days. Yoshioka et al., “Pharmacological Characterization of 5-Hydroxytryptamine-Induced Apnea in the Rat'. J. Pharmacology (21) Appl. No.: 11/916,563 and Experimental Therapeutics 1992 260(2):917-924. DeMesquita et al., “Effect of chronic intracerebroventricular infusion (22) PCT Filed: Jun. 6, 2006 of cholecystokinin on respiration and sleep', Brain Research 1986 378:127-132. (86). PCT No.: PCT/US2O06/021929 Bennet et al., "Apneic effects of cholecystokinin in unanaesthetized fetal sheep'. Journal of Developmental Physiology 1990 14:229-233. S371 (c)(1), Herranz, Rosario, "Cholecystokinin Antagonists; Pharmacological (2), (4) Date: Dec.
    [Show full text]
  • The Difference We Make
    ILLINOIS MEDICINE Illinois Medicine Fiscal Year 2009 THANKS YOU FOR YOUR CONTINUED SUPPORT Contributors Report and Honor Roll The Difference We Make OFFICE OF MEDICAL ADVANCEMENT 1747 West Roosevelt Road | Suite 302 | Chicago, IL 60608-1203 phone (312) 996-4470 | fax (312) 996-4472 | www.medicine.uic.edu | www.uillinoismedcenter.org 1107976_Output.indd07976_Output.indd 11-2-2 112/7/092/7/09 112:09:042:09:04 PPMM ILLINOIS MEDICINE The Difference We MAke Every day, the University of Illinois College of Medicine and Medical Center make a profound difference in education and health. It happens when a medical student learns a skill or concept that will be fundamental to her work as a physician in the future; when a patient receives high-quality care that puts him back on the road to health; or when a research team publishes the important fi ndings of their study. Every day, the donors to Illinois Medicine make a difference as well. Whether young or old, individuals or organizations, with gifts large or small, our supporters make a direct impact on the quality of the education and care we provide and the research we conduct. This report showcases a few of the many ways our donors have made a difference in the lives of our students and patients, and the Honor Roll at the end of this publication gratefully acknowledges all the donors who have made contributions to Illinois Medicine between July 1, 2008, and June 30, 2009. The University of Illinois College of Medicine and Medical Center thank you for your generous support.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,160,898 B2 Radulovacki Et Al
    US007160898B2 (12) United States Patent (10) Patent No.: US 7,160,898 B2 Radulovacki et al. (45) Date of Patent: Jan. 9, 2007 (54) PHARMACOLOGICAL TREATMENT FOR WO WO99/65490 12/1999 SLEEP APNEA WO WO 99,65571 12/1999 WO WOOO, 51582 9, 2000 (75) Inventors: Miodrag Radulovacki, Chicago, IL WO WO O2,361.13 5, 2002 (US); David W. Carley, Evanston, IL OTHER PUBLICATIONS (US) Armstrong et al., J. Physiol. (Lond.), 365:104 P (1985). (73) Assignee: Board of Trustees of The University Badr et al., Am. J. Respir: Crit. Care Med., 150:561-564(1994). Bennington et al., Sleep, 17:28-36 (1994). of Illinois, Urbana, IL (US) Bisgard et al., Resp. Physiol. 37:61-80 (1979). Black et al., Am. J. Physiol., 223: 1097-1102 (1972). (*) Notice: Subject to any disclaimer, the term of this Butler et al., Br. J. Pharmacol., 94:397-412 (1988). patent is extended or adjusted under 35 Carley et al., Physiol. Behav., 59:827-831 (1996). U.S.C. 154(b) by 195 days. Carley et al., Sleep, 19:363-366 (1996). Christon et al., J. Appl. Physiol. 80:2102-2107 (1996). (21) Appl. No.: 10/285,277 Coon, R.L., J. Appl. Physiol. 76:2546-2551 (1994). deBoer, Th., J. Clin. Psychiatr., 57(4):19-25 (1996). (22) Filed: Oct. 31, 2002 Devane, C. J. Clin. Psychiatry. 59(20):85-93 (1998). Douglas et al., Sleep, 23:S147-149(2000). (65) Prior Publication Data Downs et al., Laryngoscope, 105:857-861 (1995). Goda et al., European J. Pharmacology, 183/3:705-706 (1990).
    [Show full text]
  • ORL-BAL and ORL-BAL INTERNATIONAL
    ORL-BAL and ORL-BAL INTERNATIONAL Founded by the Academic Association of the Basel ORL University Department with the ORL Departments of the Cantonal Hospitals in Aarau, Liestal and Olten Switzerland www.orl-bal.info Bulletin No. 12 Activity Report for the year 2013 Presented by Prof. M. Podvinec in February 2014 Download in English and German from our homepage Members of the ORL-BAL in December 2013. Sitting, from left to right R. Koeppl, F. Metternich, S.Hasenklever. Standing: D. Bodmer, A. Arnoux, A. Welge-Lüssen, M. Podvinec The traditional series of educational events found place this year, of which the key events were seminars on lacrimal duct surgery in January in Olten, on bariatric surgery in February, and on pediatric surgery in April in Aarau. Basel offered an update on problems on the pathology of swallowing in May and an overview of problems in head and neck tumor disease. This was also the introduction of the newly appointed Assistant Professor for ORL Oncology, Stephan Haerle . Olten had prepared a seminar on the duplicity of rare cases and Liestal gave an overview of reflux disease in October. Finally, we had a stimulating end-of- the-year presentation on interesting and rare cases and the medical highlights of the year. Third Temporal Bone Course in Basel: The now traditional course was headed by Professor Daniel Bodmer, had 12 participants, one of which was a delegate from Split, Croatia. Tutors were Professor M. Podvinec and K. Tschopp, Lecturer N. Gürtler and Doctors Y. Brand, and A. Zehnder. The next course takes place in 2014, at the same venue on September 25.
    [Show full text]